Other
Selatogrel
Selatogrel is an intervention with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
COMBINATION PRODUCT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_1
3
60%
Ph phase_3
1
20%
Ph phase_2
1
20%
Phase Distribution
3
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(4)
Detailed Status
Completed4
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 13 (60.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
Trials by Status
completed480%
enrolling_by_invitation120%
Recent Activity
0 active trials
Showing 5 of 5
enrolling_by_invitationphase_3
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
NCT04957719
completedphase_1
A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants
NCT07133191
completedphase_2
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
NCT03384966
completedphase_1
The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics
NCT04406896
completedphase_1
A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects
NCT04557280
Clinical Trials (5)
Showing 5 of 5 trials
NCT04957719Phase 3
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
NCT07133191Phase 1
A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants
NCT03384966Phase 2
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
NCT04406896Phase 1
The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics
NCT04557280Phase 1
A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects
All 5 trials loaded
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 5